TABLE 1.
Measurement of anti-SHIV binding antibody endpoint titersa
| wpi | Endpoint titer for RM: |
|||
|---|---|---|---|---|
| EK23 | DV60 | DJ11 | EN03 | |
| 0 | <1:5 | <1:5 | <1:5 | <1:5 |
| 1 | <1:5 | <1:5 | <1:5 | <1:5 |
| 2 | <1:5 | <1:5 | <1:5 | <1:5 |
| 3 | <1:5 | <1:5 | <1:5 | 1:5 |
| 4 | <1:5 | <1:5 | <1:5 | 1:5 |
| 5 | <1:5 | <1:5 | <1:5 | 1:5 |
| 10 | <1:5 | <1:5 | <1:5 | 1:20 |
| 15 | <1:5 | <1:5 | <1:5 | 1:20 |
| 18 | <1:5b | <1:5 | <1:5 | 1:100 |
| 21 | <1:5 | <1:5 | 1:100 | |
| 26 | <1:5 | <1:5 | 1:100 | |
| 29 | <1:5 | <1:5 | 1:25,600 | |
| 32 | <1:5b | <1:5 | 1:25,600 | |
| 43 | <1:5b | 1:102,400 | ||
| 68 | 1:102,400b | |||
a
SHIV-specific antibody titers in longitudinal plasma samples were measured using the commercially available ELISA kit HIV-1/HIV-2 plus O EIA. Endpoint titers are reported as the last 4-fold dilution above the cutoff of the assay.
b
Time of necropsy.